Skip to content

TMS Beyond Depression & OCD

Off-Label Use of Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS) is a FDA-approved treatment used for the treatment of Depression and Obsessive-Compulsive Disorder (OCD) in adults.

Beyond its FDA approved uses, an expanding body of scientific research has demonstrated its ability to significantly reduce symptoms across a diverse array of psychiatric conditions and in children and adolescents.  We have used it to successfully to improve symptoms for numerous psychiatric conditions. 

Transforming Mental Health Care: TMS for Psychiatric Conditions

Post Traumatic Stress Disorder (PTSD)

Mitigating Anxiety, Hypervigilance, and Insomnia

Attention-Deficit Disorder (ADD/ADHD)

Improving Focus and Reducing Impulsivity

Substance & Behavioral Addictions

Curbing Cravings and Compulsive Behaviors


Stabilizing Mood Swings and Depressive Episodes


Enhancing Memory, Focus, and Executive Function

Autism Spectrum Disorder (ASD)

Facilitating Social Skills and Easing Repetitive Behaviors

Insurance Coverage and Off-Label Use of TMS

Insurance coverage for off-label use of Transcranial Magnetic Stimulation (TMS) can be challenging, as insurances typically cover only FDA-approved treatments. Recognizing this, our clinic offers transparent pricing and flexible payment plans for TMS, aiming to make this effective treatment accessible to those exploring alternatives for conditions beyond depression and OCD.

We are dedicated to ensuring that financial barriers do not prevent anyone from accessing the potential benefits of TMS, and our team is here to help you find a financial solution that fits your needs.

Post Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder (PTSD) occurs after experiencing or witnessing a traumatic event. Common symptoms include flashbacks, severe anxiety, nightmares, and uncontrollable thoughts about the trauma.


Brain Areas Targeted

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Attention-Deficit/ Hyperactivity Disorder

TMS may offer a new therapeutic strategy for ADD/ADHD by modulating neural activity in brain regions responsible for attention and executive functioning. A clinical trial by Weaver et al. (2012) indicated that TMS therapy led to significant improvements in attention and reduction in hyperactivity and impulsivity among participants, pointing towards its potential utility in ADD/ADHD management (Journal of Neural Transmission, 2012).

Substance and Behavioral Addictions

TMS therapy offers a unique approach to addiction by resetting the brain’s reward circuits, which are often dysregulated in substance use disorders. A systematic review by Diana et al. (2017) in the Neuropsychopharmacology journal posits that TMS can reduce cravings and diminish relapse rates, providing a new hope for sustainable recovery.

Bipolar Depression

The challenge of treating Bipolar Depression lies in managing both manic and depressive episodes. TMS offers a focused approach that can stabilize mood without the common side effects associated with medication. A study by Dell’Osso et al. (2014) in Clinical Practice and Epidemiology in Mental Health found that TMS improved depressive symptoms in bipolar patients, marking it as a promising adjunct therapy.

Cognitive Disorders

Cognitive disorders encompass a broad spectrum of brain impairments, with TMS showing potential to improve cognitive functions. A meta-analysis by Chou et al. (2015) in Brain Stimulation suggests that TMS can enhance cognitive performance in Alzheimer’s disease and other cognitive disorders by facilitating neuroplasticity and neural connectivity.

Autism Spectrum Disorder (ASD)

For individuals with Autism Spectrum Disorder, TMS has been explored as a method to enhance social communication and decrease repetitive behaviors by targeting and adjusting brain activity. A study by Enticott et al. (2014) in the Journal of Autism and Developmental Disorders showed promising results, with participants experiencing improvements in certain ASD-related symptoms following TMS treatment.